Gewählte Publikation:
Apsner, R; Schulenburg, A; Steinhoff, N; Keil, F; Janata, K; Kalhs, P; Greinix, H.
Cyclosporin A-induced ocular flutter after marrow transplantation.
Bone Marrow Transplant. 1997; 20(3):255-256
Doi: 10.1038/sj.bmt.1700809
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Ocular flutter is a rare neurologic condition occurring in patients suffering from viral encephalitis, intracranial neoplasia, paraneoplastic syndrome or intoxications. Neurotoxicity is a recognized complication of cyclosporin A (CsA) therapy, but ocular flutter has not been reported in association with CsA administration to date. We describe a 17-year-old female patient who developed ocular flutter 51 days after transplantation with marrow from an unrelated donor, for acute myeloid leukemia. After discontinuation of cyclosporin, which was given for prophylaxis of graft-versus-host disease, the clinical symptoms resolved within 3 weeks, but a slightly abnormal electrooculogram persisted for more than 10 months.
- Find related publications in this database (using NLM MeSH Indexing)
-
Acute Disease -
-
Adult -
-
Bone Marrow Transplantation -
-
Cyclosporine - adverse effects Cyclosporine - therapeutic use
-
Female -
-
Graft Rejection - prevention & control
-
Humans -
-
Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use
-
Leukemia, Myeloid - therapy
-
Ocular Motility Disorders - chemically induced Ocular Motility Disorders - physiopathology
-
Transplantation, Homologous -
- Find related publications in this database (Keywords)
-
cyclosporin
-
neurotoxicity
-
ocular flutter